BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Connetics Corporation

Connetics Corporation is focused on the acquisition, development and commercialization of marketed and late-stageproducts. The Company's product and commercial focus is initially targeted at rheumatology and dermatology, two specialty medical markets. These commercially attractive markets have large patient populations yet relatively small physician

treating groups. U.S. dermatologists and rheumatologists write prescriptions each year exceeding $5.0 billion. The Company's goal is to leverage these markets by commercializing novel products to meet currently unmet medical needs

and employing focused and highly trained sales staff. Connetics currently markets Ridaura(R) (auranofin), a treatment for rheumatoid arthritis, and ACTIMMUNE(R) (interferon gamma-1b), a treatment for chronic granulomatous disease (beginning January 1999). On March 1, 1999 Connetics received clearance from the FDA to begin marketing Luxiq(TM) (betamethasone valerate) Foam, 0.12%, a product to treat corticosteroid-responsive scalp dermatoses. Connetics has several other products in development: ConXn(R) (recombinant human relaxin H2) ("relaxin"), targeting scleroderma, organ fibrosis, and infertility; and OLUX(TM) (clobetasol propionate) Foam, 0.05%, a novel formulation for the treatment of severe scalp dermatoses; and interferon gamma (through its wholly-owned subsidiary, InterMune Pharmaceuticals, Inc.) for the treatment of certain congenital, infectious and other diseases.


Contact Details:
3290 West Bayshore Road
Palo Alto
CA
94303
United States of America
Tel:650 843 2800
Fax:650 843 2899
Email:
WWW:

www.connetics.com/




Loading...

Recent Publications by Connetics Corporation:

A novel foam vehicle for delivery of topical corticosteroids.
Skin, particularly the uppermost layer--the stratum corneum--presents a...
11th November, 2005
Center for Skin Biology, Connetics Corp, Palo Alto, California 94303, USA. J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S26-38.
DOI Direct Link
Simultaneous determination of tretinoin and clindamycin phosphate and their degradation products in topical formulations by reverse phase HPLC.
A new HPLC method based on reverse phase separation and photodiode-array...
9th October, 2004
Connetics Australia Pty. Ltd, 8 Macro Crt, Rowville, VIC 3178, Australia. J Sep Sci. 2004 Jan;27(1-2):71-7.
Bioavailability of clobetasol propionate in different vehicles.
Topical clobetasol propionate is widely used for the treatment of...
11th October, 2003
Connetics Corporation, Palo Alto, Calif., USA. Skin Pharmacol Appl Skin Physiol. 2003 Jul-Aug;16(4):212-6.
DOI Direct Link
Relaxin activates the MAP kinase pathway in human endometrial stromal cells.
The reproductive hormone, relaxin, is structurally similar to insulin and...
26th November, 2002
Connetics Corporation, 3400 West Bayshore Rd., Palo Alto, California J Cell Biochem. 2002;85(3):536-44.
DOI Direct Link
Systemic administration of recombinant human relaxin (RHRLX) ameliorates the acute cyclosporine nephrotoxicity in rats.
The reproductive hormone, relaxin, is structurally similar to insulin and...
16th March, 2001
Connetics Corporation, Palo Alto, CA, USA J Heart Lung Transplant. 2001 Feb;20(2):253.

View more Connetics Corporation research publications.

BioNews Results for Connetics Corporation:

Learn about the World Antibiotics Market
Street Insider:  Sep 24 2008 1:37PM Matching: connetics
Peplin hires new CEO, gets $24M in funding
Biz Journals:  Sep 8 2008 5:06AM Matching: connetics
Peplin gains $24M to fund Phase III
FierceBiotech:  Sep 2 2008 6:09PM Matching: connetics
Emeryville biotech Peplin scores $24M in funding
Biz Journals:  Sep 1 2008 4:22AM Matching: connetics

Connetics Corporation Patents:

US Patent No.Title
7222754 Aerosol system having lockable cap
5776459 TCR V beta 5 peptides
5811395 Relaxin analogs and derivatives methods and uses thereof
5911997 Relaxin-like factor and methods and uses thereof
6200953 Relaxin analogs and derivatives compositions

View more Connetics Corporation patents.

Connetics Corporation (CNCT) Financial information Links from Barchart

CNCT Quote from from Barchart.com
CNCT Chart from from Barchart.com
CNCT Profile from from Barchart.com
CNCT Opinion from from Barchart.com

View more Connetics Corporation finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 237 times since April 2007, the link to the organisation's website has been followed 45 times

Recent Search Terms used to find this page: connetics scleroderma | connetics.com | www.connetics.com | connetics press release relaxin | Connetics.com | hplc simultaneous determination of tretinoin and clindamycin | clobetasol, HPLC methods | connetics corporation relaxin | HPLC method for Auranofin | www.connetics | .

Search for more companies in Palo Alto

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Connetics Corporation
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.